Filing Details

Accession Number:
0001477932-23-006094
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-14 16:10:49
Reporting Period:
2023-08-11
Accepted Time:
2023-08-14 16:10:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1837607 Aeon Biopharma Inc. AEON () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557024 Strathspey Crown Holdings Group, Llc 4040 Macarthur Blvd.
Suite 210
Newport Beach CA 92660
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-08-11 7,380,394 $10.00 2,031,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Reflects the disposition of shares of the Issuer's Class A Common Stock (the "Distributed Shares") by the Reporting Person in connection with the repurchase of certain of the Reporting Person's membership interests held by its members in exchange for, among other consideration, the Distributed Shares.
  2. In addition to the disposition of the Distributed Shares, the amount reflected includes a reduction in the Reporting Person's beneficial ownership by an additional 8,203 shares of the Issuer's Class A Common Stock to correct an inadvertent overstatement of such ownership by such amount in the Reporting Person's Form 3 filed with the Securities and Exchange Commission on July 31, 2023.